MMND-ITRO 2025 Conference Program
- Day 1 Tuesday 18 February 2025 | MMND Conference and welcome reception
- Day 2 Wednesday 19 February 2025 | MMND Conference
- Day 3 Thursday 20 February 2025 | Special Brachytherapy Day and gala dinner
- Day 4 Friday 21 February 2025 | ITRO Conference
- Day 5 Saturday 22 February 2025 | ITRO Conference
Welcome
8.00 - 8.10
Anatoly Rozenfeld, Michael Lerch, Tomas Kron
MMND Opening
8.10 - 8.20
Eileen McLaughlin, Deputy Vice-Chancellor (Research and Sustainable Futures), University of Wollongong, Australia
Session 1: MRT
Chair: Stephanie Corde-Tehei, Michael Lerch
Session dedicated to the memory of Dr Elke Brauer-Krisch
8.20 - 8.40 | Of canines and humans - how dogs improve the quality of life in human patients with malignant brain tumours
Elisabeth Schültke, Rostock University Medical Center, Germany
8.40 - 9.00 | How submillimeter SFRT could change the radio-oncology treatment
Valentin Djonov, Department of Clinical Research, University of Bern, Switzerland
9.00 - 9.15 | Different approaches to enhance the treatment effectiveness of MRT in a preclinical breast cancer model
Olga Martin, Centre for Medical Radiation Physics, University of Wollongong, Australia
9.15 - 9.30 | The first canine osteosarcoma treatment with microbeam radiation therapy
Elette Engels, Centre for Medical Radiation Physics, University of Wollongong, Australia
9.30 - 9.50 | High dose rate microbeam and minibeam radiation therapy without synchrotrons
Stefan Bartzsch, Institute for Radiation Oncology, Technical University of Munich, Germany
9.50 - 10.10 | SFRT at the Mayo Clinic: Now and the near future
Sean Park, Mayo Clinic, USA
10.10 - 10.30 | Where to from here: upwards, sideways, or down under?
Daniel Hausermann, ANSTO Australian Synchrotron, Melbourne, Australia
10.30 - 11.00 | Break
Morning Tea
Session 2: Micro-Nano-Dosimetry
Chair: Linh Tran, James Vohradsky
Session dedicated to the memory of Professor Harald Rossi
11.00 - 11.20 | Micro- and nanodosimetry for hadrontherapy
Stefano Agosteo, Polytechnic University of Milan, Italy
11.20 - 11.35 | Microdosimetry for BNCT: New detectors for beam quality monitoring
Anna Selva, INFN Legnaro National Laboratories, Legnaro (PD), Italy
11.35 - 11.50 | RBE Evaluation of a 2D Ripple Filter Applied in Carbon Ion Therapy Using Microdosimetric Methods
Mei Xiao, Shanghai Proton and Heavy Ion Center, Shanghai, China
11.50 - 12.00 | Dose evaluation of in-field and out-of-field for superficial target in spot-scanning proton therapy using the microdosimetric function in PHITS
Gaku Iwata, University of Tsukuba, Japan
12.00 - 12.10 | Recent development of SOI microdosimetry at CMRP
Anatoly Rozenfeld, Centre for Medical Radiation Physics, University of Wollongong, Australia
12.10 - 12.20 | SOI microdosimetry for particle therapy and space applications - 1
Linh Tran, Centre for Medical Radiation Physics, University of Wollongong, Australia
12.20 - 12.30 | SOI microdosimetry for particle therapy and space applications - 2
- Vladimir Pan, Centre for Medical Radiation Physics, University of Wollongong, Australia
- James Vohradsky, Centre for Medical Radiation Physics, University of Wollongong, Australia
12.30 - 13.30 | Break
Lunch (posters viewing 13.00 - 13.30)
Session 3: Proton-Heavy Ions Therapy 1
Chair: Vladimir Pan, Jacinta Yap
13.30 - 13.50 | Technical preparations for the first carbon-ion therapy facility in the United States
Chris Beltran, School of Medicine, Mayo Clinic, USA
13.50 - 14.10 | Quantum scalpel research project at QST
Taku Inaniwa, National Institute for Quantum Science and Technology, Japan
14.10 - 14.30 | Innovations in accelerator technology for particle therapy
Dale Prokopovich, MedAustron, Austria
14.30 - 14.45 | Technology for Ultra Rapid Beam Operation (TURBO): Scaling down and speeding up particle therapy
Jacinta Yap, University of Melbourne, Australia
14.45 - 15.00 | VHEE radiotherapy research at PEER
James Cayley, Centre for Medical Radiation Physics, University of Wollongong, Australia
15.00 - 15.30 | Break
Afternoon Tea
Session 4: Proton-Heavy Ions Therapy 2
Chair: Taku Inaniwa, Katia Parodi
15.30 - 15.45 | Let the Dr Calc in: evaluation of clinical dose rate for proton PBS delivery
Nick Depauw, MGH, Harvard Medical School, USA
15.45 - 16.00 | Exploratory study of proton arc for prostate bed patient with bilateral metallic hip prostheses
Suresh Rana, Lynn Cancer Institute, Boca Raton Regional Hospital, USA
16.00 - 16.15 | Implementation of temporally modulated pulsated proton radiotherapy
Andrew Wroe, Miami Cancer Institute, USA
16.15 - 16.35 | Advancements in the Treatment and Treatment Planning Malignant Brain Tumors with Charged Particles, BNCT, and Alternating Electric Fields
Reinhard Schulte, Loma Linda University, USA
16.35 - 16.50 | Dosimetry tools for emerging proton therapies
Severine Rossomme, IBA Dosimetry, Belgium
Session 5: FLASH Radiation Therapy
Chair: Valentin Djonov, Olga Martin
16.50 - 17.20 | FLASH to overcome radiation resistance
Marie Catherine Vozenin, Swiss Cancer Centre, Switzerland
Welcome Reception
18.00 - 19.30 | Oyster Dispense Bar, Sheraton Grand Sydney Hyde Park
Session 1: AI in Radiation Therapy
Chair: Susanna Guatelli, Dale Prokopovich
8.00 - 8.20 | AI-driven automation in radiation therapy to improve treatment outcomes
Maria Thor, Memorial Sloan Kettering Cancer Centre, USA
8.20 - 8.40 | Deep learning-based dose engine for external X-ray radiotherapy
Susanna Guatelli, Centre for Medical Radiation Physics, University of Wollongong, Australia
Session 2: Space Radiation
Chair: Stefania Peracchi, Anatoly Rozenfeld
8.40 - 9.00 | Deep space radiation measurements and crew radiation protection for the NASA Artemis program
Stuart George, Space Radiation Analysis Group, NASA, USA
9.00 - 9.15 | Challenges and performance of different detector systems in characterising the GCR-simulator at GSI
Enrico Pierobon, GSI Helmholtzzentrum für Schwerionenforschung, Germany
9.15 - 9.30 | Bringing space to earth: an insight into the (stage 2) GCR simulator at GSI-fair
Luca Lunati, GSI Helmholtzzentrum für Schwerionenforschung, Germany
Session 3: Precision Treatment with Image Guidance Session
Chair: Lois Holloway, Peter Metcalfe
9.30 - 9.50 | The SIRMIO platform for advanced image-guided precision small animal irradiation: from the initial idea to the first in-vivo mice applications
Katia Parodi, Ludwig-Maximilians-Universität München (LMU Munich), Germany
9.50 - 10.10 | A new outlook for efficient adaptive proton therapy
Stefan Both, University Medical Center Groningen, The Netherlands
10.10 - 10.30 | Implementation of an upright cone beam CT imaging platform for radiation therapy: Initial clinical trial results
Nick Hardcastle, Peter MacCallum Cancer Centre, Australia
10.30 - 11.00 | Break
Morning Tea
11.00 - 11.10 | Prospects and clinical practice of proton therapy used for stereotactic radiosurgery
Yang Wang, Guangzhou Tradition Chinese Medicine University Hospital, China
11.10 - 11.20 | Technological review of online Adaptive Radiotherapy (ART) for pelvic malignancies treatment in ensuring the accuracy and efficiency
Yeming Liu, Guangzhou Tradition Chinese Medicine University Hospital, China
Session 4: Advanced Detectors for Radiation Therapy
Chair: Marco Petasecca, Jeannie Wong
11.20 - 11.40 | Development of dosimeters with advanced materials for clinical radiotherapy
Cinzia Talamonti, University of Florence, Italy
11.40 - 12.00 | Advancing real-time dosimetry in diagnostic radiology
Jeannie Wong, Universiti Malaya, Malaysia
12.00 - 12.15 | The Bergen proton CT: quasi-online dose plan verification and online dose delivery monitoring
Dieter Roehrich, University of Bergen, Norway
12.15 - 12.30 | Development of flexible thin-film solar cell real-time in vivo dosimetry and LET verification system: low-cost, fast, and versatile for therapeutic electron, photon and proton beams
Adam Yeo, Peter MacCallum Cancer Centre, Australia
12.30 - 13.30 | Break
Lunch (posters viewing 13.00 - 13.30)
Session 5: BNCT and NCEPT and Alpha Therapy
Chair: Reinhard Schulte, Anna Selva
Session dedicated to the memory of Prof Barry Allen
13.30 - 13.50 | NCEPT: Current status and future development
Mitra Safavi-Naeni, ANSTO, Australia
13.50 - 14.05 | Measurement of neutron beam of IBNCT001 and validation of calculation accuracy of Tsukuba-plan for BNCT
Hiroaki Kumada, University of Tsukuba, Japan
14.05 - 14.20 | Current status and recent technologies in quality assurance of an accelerator based boron neutron capture therapy system
Naonori Hu, Kansai BNCT Medical Center, Japan
14.20 - 14.30 | Nanoboron based targeted boron neutron capture therapy for malignant glioma
Rameshwar Patil, Loma Linda University, USA
14.30 - 14.45 | I-Vitro and microdosimetric study of Neutron Capture Enhanced Proton Therapy in a neutron enhanced proton beam
Villads Jacobsen, Aarhus University Hospital, Denmark
14.45 - 15.00 | Geant4 simulation of the enhanced 220Rn spread in DaRT
Jaap Velthuis, University of Bristol, United Kingdom
15.00 - 15.15 | Monte Carlo Modeling of AlphaDART: Dosimetry and Detectors
Dean Cutajar, Centre for Medical Radiation Physics, University of Wollongong, Australia
15.15 - 15.40 | Break
Afternoon Tea
Session 6: Imaging and Technology Transfer
Chair: Michael Jackson, Katia Parodi
15.40 - 16.00 | Advances in radiological imaging: Where are we now and where we are going
William Rae, Prince of Wales Hospital, Australia
16.00 - 16.15 | Fibre-optic dosimeters and their applications in medical radiation therapy: a review
Enbang Li, CMRP, University of Wollongong, Australia
16.15 - 16.30 | Next generation detector for high resolution and high sensitivity PET systems with a variety of geometries
Taiga Yamaya, National Institutes for Quantum Science and Technology, Japan
16.30 - 16.45 | In-situ tumour diagnosis by means of range-verification PET in carbon ion therapy
Chie Toramatsu, National Institutes for Quantum Science and Technology, Japan
16.45 - 17.05 | On potential use of the relativistic Doppler effect to enhance the resolution of PET
Stanislav Pospíšil, Institute of Applied Physics, Technical University in Prague, Czech Republic
17.05 - 11.25 | RBE Evaluation of a 2D Ripple Filter Applied in Carbon Ion Therapy Using Microdosimetric Methods
Mei Xiao, Shanghai Proton and Heavy Ion Center, Shanghai, China
17.25 - 17.40 | Education of radiotherapy workforce for advanced therapy
Tomas Kron, Peter MacCallum Cancer Centre, Australia
Official Close of MMND Conference
17.40 - 17.45
Anatoly Rozenfeld, Michael Lerch, Tomas Kron
Welcome and Opening Remarks
8.00 - 8.10
Anatoly Rozenfeld, Joel Poder, Michael Zelefsky
Session 1: Prostate / Advanced Imaging
Chair: Joel Poder, Anatoly Rosenfeld
8.10 - 8.45 | Identification of dominant intra-prostatic lesions on mpMRI: Applications with brachytherapy
Annette Haworth, Institute of Medical Physics, University of Sydney, Australia
8.45 - 9.15 | Prostate cancer management in the PSMA PET era from a urologists perspective
David Malouf, Department of Urology, St George Hospital, Australia
9.15 - 9.50 | Focal prostate brachytherapy, time for a resurgence?
Michael Zelefsky, NYU Langone, USA
9.50 - 10.30 | Break
Morning Tea
Session 2: Physics
Chair: Annette Haworth, Adam Yeo
10.30 - 11.00 | Image registration and dose accumulation in brachytherapy
Gil Cohen, NYU Langone, USA
11.00 - 11.30 | Artificial intelligence applications in brachytherapy
Joel Poder, St George Hospital Cancer Care Centre, Australia
11.30 - 12.00 | Is in-vivo dosimetry/source tracking ready for routine clinical use?
Ryan Smith, The Alfred Hospital, Australia
12.00 - 13.00 | Break
Lunch (posters viewing 12.30 - 13.00)
Session 3: Physics Snap Orals
Chair: Annette Haworth, Adam Yeo
13.00 - 13.10 | Development of an MR-only needle reconstruction protocol for interstitial image guided adaptive brachytherapy for cervical cancer
Marissa Kielly, Prince of Wales Hospital, Australia
13.10 - 13.20 | Radiation field considerations when treating non-melanoma skin cancers with rhenium-188-a Monte Carlo study
David Bolst, Centre for Medical Radiation Physics, University of Wollongong, Australia
13.20 - 13.30 | Robust optimisation in HDR prostate brachytherapy including all major uncertainty sources
Andrew Kennedy, University of Adelaide, Australia
Session 4: Skin & Paediatrics
Chair: Soo Min Heng, Dinesh Vignarajah
13.30 - 14.00 | Paediatric brachytherapy
Jennifer Chard, Peter MacCallum Cancer Centre, Melbourne, Australia
14.00 - 14.30 | Skin brachytherapy - RT perspective
- Steph Miller, The Alfred Hospital, Australia
- Lyndal Newmarch, Royal Adelaide Hospital, Australia
14.30 - 15.00 | Skin brachytherapy - Physics perspective
- John Lawson, Royal Adelaide Hospital, Australia
- Sally McKinnon, Royal Adelaide Hospital, Australia
15.00 - 15.30 | Break
Afternoon Tea
Session 5: Miscellaneous
Chair: Jennifer Chard, Michael Jackson
15.30 - 15.50 | Combining BT with SABR in the setting of UIR and HR prostate cancer - what is the preferred strategy?
Michael Zelefsky, NYU Langone, USA
15.50 - 16.10 | Locoregional control and survival in cervix cancer
Kailash Narayan, ICON Cancer Centre, Freemasons, Australia
16.10 - 16.30 | Eye plaque brachytherapy
Wenchang Wong, Prince of Wales Hospital, Australia
16.30 - 17.00 | Theranostics: a new era in cancer care
Erin Angel, GE HeathCare, USA
Closing Remarks
17.00 - 17.10
Anatoly Rozenfeld, Joel Poder, Michael Zelefsky
MMND-ITRO Gala Dinner
18.00 - 22.00 | QVB Tea Room
Gala Dinner theme: "Silver Jubilee" - see MMND-ITRO Social program for more details.
Welcome and Opening Remarks
8.00 - 8.10
Anatoly Rozenfeld, Josh Yamada, Michael Jackson, Joseph Bucci
Session 1: Genitourinary (GU)
Chair: Joseph Bucci and Marketa Skala
8.10 - 8.40 | MRI Linac and its potential impact for the treatment of prostate cancer
Michael Zelefsky, NYU Langone Medical Center, USA
8.40 - 9.00 | GU Tumour Board
- Michael Zelefsky, NYU Langone Medical Center, USA
- Carl Rossi, California Protons Cancer Therapy Centre, USA
- Joseph Bucci, St George Cancer Care Centre, Australia
Session 2: Gastrointestinal (GI)
Chair: Jeremy de Leon
9.00 - 9.30 | Practice changing HCC RT trials
Laura Dawson, Princess Margaret Cancer Centre, Canada
9.30 - 10.00 | Proton therapy & GI malignancies
James Metz, Perelman School of Medicine, University of Pennsylvania, USA
10.00 - 10.30 | Break
Morning Tea
10.30 - 10.50 | GI Tumour Board
- Laura Dawson, Princess Margaret Cancer Centre, Canada
- James Metz, Perelman School of Medicine, University of Pennsylvania, USA
- Jeremy de Leon, GenesisCare, Australia
Session 3: Spine
Chair: Philip Chan
10.50 - 11.10 | Reirradiation of spine
Josh Yamada, Memorial Sloan Kettering Cancer Center, USA
11.10 - 11.30 | Update on spine SBRT
Josh Yamada, Memorial Sloan Kettering Cancer Center, USA
11.30 - 12.00 | Spine Tumour Board
- Josh Yamada, Memorial Sloan Kettering Cancer Center, USA
- Jose Penagaricano, Moffitt Cancer Center, USA
- Philip Chan, Royal Brisbane Hospital, Australia
12.00 - 13.00 | Break
Lunch (poster viewing 12.30 - 13.00)
Session 4: Proton
Chairs: Verity Ahern, Michael Penniment
13.00 - 13.15 | The Past is Prologue
Carl Rossi, California Protons Cancer Therapy Centre, USA
13.15 - 13.30 | ALARA, Where Art Thou?
Carl Rossi, California Protons Cancer Therapy Centre, USA
13.30 - 14.00 | Proton therapy…here today… or gone in a FLASH
James Metz, Perelman School of Medicine, University of Pennsylvania, USA
Session 5: Head and Neck (H&N)
Chair: Dion Forstner and Penny McKenzie
14.00 - 14.30 | Rethinking radiation oncology: towards personalisation using HPV oropharyngeal cancer as a model
Nancy Lee, Memorial Sloan Kettering Cancer Center, USA
14.30 - 15.00 | H&N Tumour Board
- Nancy Lee, Memorial Sloan Kettering Cancer Center, USA
- Dion Forstner, GenesisCare, Australia
15.00 - 15.30 | Break
Afternoon Tea
15.30 - 16.00 | Positron emission tomography imaging of the immune system in patients treated with radiation therapy
Michael Macmanus, Peter MacCallum Cancer Centre, Melbourne, Australia
Session 6: Lung
Chair: Rowena Martin
16.00 - 16.30 | Radiation therapy for thymic tumours - for all, some or none?
Andreas Rimner, Department of Radiation Oncology, University of Freiburg, Germany
16.30 - 16.50 | Lung Tumour Board
- Rowena Martin,
- Andreas Rimner, Department of Radiation Oncology, University of Freiburg, Germany
- Sean Park, Mayo Clinic, USA
Session 7: Special Topics
Chair: Anatoly Rozenfeld
16.50 - 17.10 | Emerging Technologies in Proton Therapy
Stefan Both, University Medical Center Groningen, The Netherlands
Keynote 1
17.10 - 17.50 | Radiation - anti-inflammatory and immunostimulant. Panacea or placebo?
Michael Jackson, Prince of Wales Hospital, Australia
Session 1: Physics
Chair: Tomas Kron
8.10 - 8.40 | Radiobiological principles in SBRT: Understanding efficacy and safety
Wolfgang Tomé, Montefiore Medical Centre, USA
8.40 - 9.10 | Upright radiotherapy: How might it differ?
Thomas "Rock" Mackie, LEO Cancer Care, USA
9.10 - 9.40 | AI-powered targeted radiotherapy to halve treatment side effects for cancer patients
Paul Keall, University of Sydney, Australia
9.40 - 10.00 | Dosimetric challenges of novel irradiation modalities for decreasing toxicities: from FLASH to minibeam radiotherapy
Francesco Romano, INFN Catania, Italy
10.00 - 10.30 | Break
Morning Tea
Session 2:
Chair: Michael Jackson
10.30 - 11.00 | Evolution of clinical spatially fractionated (GRID) radiation therapy
José Peñagarícano, Moffitt Cancer Center, USA
11.00 - 11.20 | Homologous recombination repair promotes mitotic death to suppress the immune response after ablative radiotherapy
Harriet Gee, Radiation Oncology Network, Western Sydney Local Health District, Australia
11.20 - 11.30 | Radiotherapy in Benign Disease
Gerald Fogarty, Icon Cancer Centre
11.30 - 11.40 | Long term radiotherapy outcomes of early-stage primary gastric diffuse large B-cell lymphoma: a multi-centre retrospective study
Eric Fong, Prince of Wales Hospital, Sydney, Australia
11.40 - 11.50 | New Imaging on the Linac
Sean Hood, CMRP, University of Wollongong, Australia
Keynote 2
11.50 - 12.30 | Advanced QA in radiation therapy: 25 years of semiconductor dosimetry development at CMRP
Anatoly Rozenfeld, Centre for Medical Radiation Physics, University of Wollongong, Australia
Official Close of ITRO Conference
12.30 - 12.40
Anatoly Rozenfeld, Josh Yamada, Michael Jackson, and Joseph Bucci